regorafenib,pazopanib
bayer,novartis
['pazopanib', 'sarcoma', 'regorafenib']
interesting poster at #asco22: #regorafenib in pts with non-adipocytic soft tissue sarcoma #nasts. clinical pfs benefit associated with regorafenib in all #nasts patients irrespective of prior #pazopanib treatment. abstract: 11555 poster: 459
#meded
Independent and international experts in GI oncology supporting medical oncologists to give the best possible care to patients. Part of https://t.co/Y8pV8OaxOB